BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26267211)

  • 21. Shedding light on Alzheimer's β-amyloid aggregation with chemical tools.
    Kapurniotu A
    Chembiochem; 2012 Jan; 13(1):27-9. PubMed ID: 22113851
    [No Abstract]   [Full Text] [Related]  

  • 22. Understanding the molecular basis for the inhibition of the Alzheimer's Abeta-peptide oligomerization by human serum albumin using saturation transfer difference and off-resonance relaxation NMR spectroscopy.
    Milojevic J; Esposito V; Das R; Melacini G
    J Am Chem Soc; 2007 Apr; 129(14):4282-90. PubMed ID: 17367135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
    Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
    Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of metal ions in the self-assembly of the Alzheimer's amyloid-β peptide.
    Faller P; Hureau C; Berthoumieu O
    Inorg Chem; 2013 Nov; 52(21):12193-206. PubMed ID: 23607830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different effects of Alzheimer's peptide Aβ(1-40) oligomers and fibrils on supported lipid membranes.
    Canale C; Seghezza S; Vilasi S; Carrotta R; Bulone D; Diaspro A; San Biagio PL; Dante S
    Biophys Chem; 2013 Dec; 182():23-9. PubMed ID: 23998637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-toxic conformer of amyloid β may suppress amyloid β-induced toxicity in rat primary neurons: implications for a novel therapeutic strategy for Alzheimer's disease.
    Izuo N; Murakami K; Sato M; Iwasaki M; Izumi Y; Shimizu T; Akaike A; Irie K; Kume T
    Biochem Biophys Res Commun; 2013 Aug; 438(1):1-5. PubMed ID: 23747423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Towards ratiometric sensing of amyloid fibrils in vitro.
    Freire S; Rodríguez-Prieto F; Ríos Rodríguez MC; Penedo JC; Al-Soufi W; Novo M
    Chemistry; 2015 Feb; 21(8):3425-34. PubMed ID: 25572280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optical trapping for the characterization of amyloid-beta aggregation kinetics.
    Veloso AJ; Yoshikawa H; Cheng XR; Tamiya E; Kerman K
    Analyst; 2011 Oct; 136(20):4164-7. PubMed ID: 21874168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro oligomerization and fibrillogenesis of amyloid-beta peptides.
    Benseny-Cases N; Klementieva O; Cladera J
    Subcell Biochem; 2012; 65():53-74. PubMed ID: 23224999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aggregation-Prone Amyloid-β⋅Cu(II) Species Formed on the Millisecond Timescale under Mildly Acidic Conditions.
    Pedersen JT; Borg CB; Michaels TC; Knowles TP; Faller P; Teilum K; Hemmingsen L
    Chembiochem; 2015 Jun; 16(9):1293-7. PubMed ID: 25989377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of early stages of amyloid Aβ13-23 formation using molecular dynamics simulation in implicit environments.
    Bajda M; Filipek S
    Comput Biol Chem; 2015 Jun; 56():13-8. PubMed ID: 25749181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of tachykinin neuropeptides on amyloid β aggregation.
    Flashner E; Raviv U; Friedler A
    Biochem Biophys Res Commun; 2011 Apr; 407(1):13-7. PubMed ID: 21352807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous measurement of a range of particle sizes during Aβ1-42 fibrillogenesis quantified using fluorescence correlation spectroscopy.
    Mittag JJ; Milani S; Walsh DM; Rädler JO; McManus JJ
    Biochem Biophys Res Commun; 2014 May; 448(2):195-9. PubMed ID: 24769478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In situ monitoring Alzheimer's disease β-amyloid aggregation and screening of Aβ inhibitors using a perylene probe.
    Li M; Zhao C; Yang X; Ren J; Xu C; Qu X
    Small; 2013 Jan; 9(1):52-5. PubMed ID: 22976818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A method for evaluating the level of soluble β-amyloid(1-40/1-42) in Alzheimer's disease based on the binding of gelsolin to β-amyloid peptides.
    Yu Y; Zhang L; Li C; Sun X; Tang D; Shi G
    Angew Chem Int Ed Engl; 2014 Nov; 53(47):12832-5. PubMed ID: 25244702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heme binding induces dimerization and nitration of truncated β-amyloid peptide Aβ16 under oxidative stress.
    Thiabaud G; Pizzocaro S; Garcia-Serres R; Latour JM; Monzani E; Casella L
    Angew Chem Int Ed Engl; 2013 Jul; 52(31):8041-4. PubMed ID: 23788407
    [No Abstract]   [Full Text] [Related]  

  • 38. Exploring the Alzheimer amyloid-β peptide conformational ensemble: A review of molecular dynamics approaches.
    Tran L; Ha-Duong T
    Peptides; 2015 Jul; 69():86-91. PubMed ID: 25908410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aluminum, copper, iron and zinc differentially alter amyloid-Aβ(1-42) aggregation and toxicity.
    Bolognin S; Messori L; Drago D; Gabbiani C; Cendron L; Zatta P
    Int J Biochem Cell Biol; 2011 Jun; 43(6):877-85. PubMed ID: 21376832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engineering of a peptide probe for β-amyloid aggregates.
    Aoraha E; Candreva J; Kim JR
    Mol Biosyst; 2015 Aug; 11(8):2281-9. PubMed ID: 26073444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.